TR-1: Standard form for notification of major holdings
TORONTO, ONTARIO, Feb. 03, 2024 (GLOBE NEWSWIRE) — TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS […]
Lancaster Resources Completes Unit Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 02, […]
RecycLiCo Battery Materials Announces Zarko Meseldzija resigns from the Board of Directors
SURREY, British Columbia, Feb. 02, 2024 (GLOBE NEWSWIRE) — RecycLiCo Battery Materials Inc. (“RecycLiCo” or the “Company”), TSX.V: AMY, OTCQB: […]
Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
SAN CARLOS, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity […]
Voxtur Announces the Issuance of Shares in Connection with the Acquisition of MTE
TORONTO and Tampa, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) — Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) (“Voxtur” or the […]
Topicus.com Inc. Defers Release Date for Fourth Quarter Results
TORONTO, Feb. 02, 2024 (GLOBE NEWSWIRE) — Topicus.com Inc. (TSXV:TOI) (the “Company”) announced today that the release of its fourth […]
AutoZone to Release Second Quarter Fiscal 2024 Earnings February 27, 2024
MEMPHIS, Tenn., Feb. 02, 2024 (GLOBE NEWSWIRE) — AutoZone, Inc. (NYSE: AZO), the leading retailer and distributor of automotive replacement […]
Hanna Announces Transfer of Listing to NEX
TORONTO, Feb. 02, 2024 (GLOBE NEWSWIRE) — Hanna Capital Corp. (the “Corporation”) (TSX Venture Exchange: HCC) (Frankfurt: 04U1) announces that it […]
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, Feb. 02, 2024 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical […]
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 02, 2024 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage […]
